TP53 and acute myeloid leukemia: Given the high frequency of monosomy 7, complex/monosomal karyotypes and TP53 variants, which may be associated with disease progression and development of MDS/AML, HSCT should be considered early, especially when these aberrations are discovered in the context of clonal evolution and bone marrow dysplasia.